Header Logo

Sefer Gezer

Concepts (155)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myelodysplastic Syndromes
15
2004
33
0.590
Why?
Antiphospholipid Syndrome
1
2003
5
0.220
Why?
Bone Marrow
10
2001
76
0.200
Why?
Apoptosis
8
1999
213
0.180
Why?
Thrombosis
1
2021
54
0.180
Why?
Thalidomide
3
2004
7
0.150
Why?
Tumor Necrosis Factor-alpha
4
2004
189
0.130
Why?
Leukemia, Myeloid, Acute
4
2001
51
0.120
Why?
Antineoplastic Agents
3
2004
198
0.120
Why?
Leukemia, Promyelocytic, Acute
2
1998
5
0.110
Why?
Tretinoin
2
1998
15
0.110
Why?
Interphase
4
1990
5
0.110
Why?
Blood Coagulation
1
2011
20
0.090
Why?
Cytokines
4
2001
222
0.090
Why?
Genetic Testing
1
2011
57
0.090
Why?
Venous Thrombosis
1
2011
46
0.080
Why?
Pulmonary Embolism
1
2011
63
0.080
Why?
Hematopoietic Stem Cells
4
1999
10
0.080
Why?
Humans
26
2021
27074
0.080
Why?
Biomarkers
2
2011
562
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2000
245
0.080
Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
9
0.080
Why?
Male
13
2011
14774
0.060
Why?
Cell Cycle
3
1997
34
0.060
Why?
Antibodies, Monoclonal
2
2004
177
0.060
Why?
Bromodeoxyuridine
3
1997
10
0.060
Why?
Proto-Oncogenes
1
2004
4
0.060
Why?
Female
11
2011
15214
0.060
Why?
Arsenicals
1
2004
12
0.060
Why?
Oxides
1
2004
16
0.060
Why?
Immunosuppressive Agents
2
2004
120
0.060
Why?
Aged
11
2011
8998
0.050
Why?
Drug Resistance, Neoplasm
1
2004
69
0.050
Why?
Transcription Factors
1
2004
169
0.050
Why?
Pilot Projects
4
2011
420
0.050
Why?
Arthroplasty, Replacement, Knee
1
2011
637
0.050
Why?
Transforming Growth Factor beta
3
2001
87
0.050
Why?
DNA-Binding Proteins
1
2004
276
0.050
Why?
Aged, 80 and over
7
2011
4777
0.050
Why?
Middle Aged
10
2011
8925
0.050
Why?
Prevalence
1
2003
443
0.050
Why?
Cytarabine
3
2001
11
0.050
Why?
Adult
6
2021
7833
0.050
Why?
Bone Marrow Cells
1
2001
51
0.050
Why?
Anemia
1
2001
34
0.050
Why?
Blood Transfusion
1
2001
67
0.050
Why?
DNA, Neoplasm
2
1998
23
0.040
Why?
Connective Tissue
2
1996
24
0.040
Why?
Palliative Care
1
2000
110
0.040
Why?
Cytogenetic Analysis
3
2004
6
0.040
Why?
Remission Induction
3
2004
90
0.040
Why?
Hematopoiesis
4
2001
11
0.040
Why?
Ecchymosis
1
1998
2
0.040
Why?
Severity of Illness Index
1
2021
879
0.040
Why?
Cell Division
4
2001
86
0.040
Why?
Idoxuridine
1
1997
2
0.040
Why?
Cell Lineage
3
2004
24
0.030
Why?
Cysteine Endopeptidases
1
1996
11
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1996
19
0.030
Why?
Leukemia, Myeloid
2
1995
4
0.030
Why?
Endopeptidases
1
1996
21
0.030
Why?
DNA
3
1997
106
0.030
Why?
Treatment Outcome
5
2004
3485
0.030
Why?
Macrophages
3
2001
102
0.030
Why?
Tumor Cells, Cultured
2
1992
129
0.030
Why?
Phenotype
2
2011
312
0.030
Why?
Risk Factors
2
2011
2302
0.020
Why?
Hemoglobins
2
2001
33
0.020
Why?
Time Factors
2
2001
1433
0.020
Why?
Mitoxantrone
2
2001
4
0.020
Why?
Blood Cell Count
2
2001
12
0.020
Why?
Pedigree
1
2011
65
0.020
Why?
Chi-Square Distribution
1
2011
139
0.020
Why?
Amifostine
2
2000
3
0.020
Why?
Monosomy
1
1990
1
0.020
Why?
Preoperative Care
1
2011
117
0.020
Why?
Leukemia, Monocytic, Acute
1
1990
4
0.020
Why?
Chromosome Deletion
1
1990
16
0.020
Why?
Anticoagulants
1
2011
87
0.020
Why?
Case-Control Studies
2
2001
587
0.020
Why?
Patient Selection
1
2011
194
0.020
Why?
Antigens, CD34
2
2001
12
0.020
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1989
8
0.020
Why?
Nucleoproteins
1
1988
2
0.020
Why?
Antigens, Neoplasm
1
1989
41
0.020
Why?
Superoxides
1
1988
25
0.020
Why?
Genetic Predisposition to Disease
1
2011
381
0.020
Why?
Fatal Outcome
1
2008
54
0.020
Why?
Disease Progression
2
2004
673
0.020
Why?
Risk Assessment
1
2011
625
0.020
Why?
Cell Differentiation
1
1988
137
0.020
Why?
Chicago
1
2011
950
0.020
Why?
DNA Fragmentation
2
1996
6
0.020
Why?
DNA Replication
2
1996
10
0.020
Why?
S Phase
2
1999
11
0.020
Why?
Interleukin-1
2
1996
48
0.020
Why?
Surveys and Questionnaires
1
2011
1144
0.020
Why?
Anemia, Refractory
1
2004
1
0.010
Why?
Pancytopenia
1
2004
3
0.010
Why?
Chromosome Aberrations
1
2004
17
0.010
Why?
Infliximab
1
2004
17
0.010
Why?
MDS1 and EVI1 Complex Locus Protein
1
2004
3
0.010
Why?
Zinc Fingers
1
2004
12
0.010
Why?
Spleen
1
2004
30
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
137
0.010
Why?
Drug Therapy, Combination
1
2004
161
0.010
Why?
Acute Disease
2
1995
176
0.010
Why?
Patient Compliance
1
2004
150
0.010
Why?
Transforming Growth Factor alpha
1
2001
7
0.010
Why?
Lymphokines
1
2001
10
0.010
Why?
Vascular Endothelial Growth Factors
1
2001
15
0.010
Why?
Platelet Count
1
2001
16
0.010
Why?
Endothelial Growth Factors
1
2001
11
0.010
Why?
Fetal Blood
1
2001
13
0.010
Why?
Coculture Techniques
1
2001
29
0.010
Why?
Endothelium
1
2001
14
0.010
Why?
Adipocytes
1
2001
22
0.010
Why?
Microscopy, Electron
1
2001
65
0.010
Why?
Cell Culture Techniques
1
2001
36
0.010
Why?
Maximum Tolerated Dose
1
2001
13
0.010
Why?
Fibroblasts
1
2001
58
0.010
Why?
Stromal Cells
1
2001
34
0.010
Why?
Vascular Endothelial Growth Factor A
1
2001
75
0.010
Why?
Drug Administration Schedule
1
2001
158
0.010
Why?
Immunohistochemistry
1
2001
366
0.010
Why?
Radiation-Protective Agents
1
2000
4
0.010
Why?
Anorexia
1
2000
3
0.010
Why?
Pentoxifylline
1
2000
6
0.010
Why?
Ciprofloxacin
1
2000
11
0.010
Why?
Hematologic Diseases
1
2000
10
0.010
Why?
Hypotension
1
2000
26
0.010
Why?
Dexamethasone
1
2000
34
0.010
Why?
Gastrointestinal Diseases
1
2000
30
0.010
Why?
Karyotyping
1
1999
11
0.010
Why?
In Situ Nick-End Labeling
1
1999
15
0.010
Why?
Age Factors
1
2001
766
0.010
Why?
Prognosis
1
2000
785
0.010
Why?
Sialoglycoproteins
1
1996
9
0.010
Why?
Cysteine Proteinase Inhibitors
1
1996
6
0.010
Why?
Oligopeptides
1
1996
21
0.010
Why?
Interleukin 1 Receptor Antagonist Protein
1
1996
14
0.010
Why?
Caspase 1
1
1996
16
0.010
Why?
Diagnosis, Differential
1
1998
348
0.010
Why?
Leukemia
1
1996
4
0.010
Why?
Lymphoma, Non-Hodgkin
1
1996
36
0.010
Why?
Cohort Studies
1
2001
1890
0.010
Why?
Biopsy
1
1995
201
0.010
Why?
Models, Biological
1
1996
322
0.010
Why?
Adolescent
1
1999
2172
0.010
Why?
Tritium
1
1992
9
0.010
Why?
Dose-Response Relationship, Drug
1
1992
333
0.010
Why?
Metaphase
1
1990
2
0.010
Why?
Nucleic Acid Hybridization
1
1990
9
0.010
Why?
Chromosome Mapping
1
1990
42
0.010
Why?
Regeneration
1
1989
19
0.000
Why?
Gezer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (155)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_